Clinical Trial Update: Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating metformin in combination with cisplatin and paclitaxel for advanced esophageal squamous cell carcinoma (ECM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• metformin (metformin)

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN